Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nick Andrews

Showing results (141-150 of 364) with videos related to

Pageof 37
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 22, 2014
A case-control study to estimate the effectiveness of maternal pertussis vaccination in protecting newborn infants in England and Wales, 2012-2013Gavin Dabrera, Gayatri Amirthalingam, Nick Andrews, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 20, 2020
Characteristics of Invasive Pneumococcal Disease Caused by Emerging Serotypes After the Introduction of the 13-Valent Pneumococcal Conjugate Vaccine in England: A Prospective Observational Cohort Study, 2014-2018Zahin Amin-Chowdhury, Sarah Collins, Carmen Sheppard, et al.
Nature Medicine|January 19, 2022
Effectiveness of COVID-19 booster vaccines against COVID-19-related symptoms, hospitalization and death in EnglandNick Andrews, Julia Stowe, Freja Kirsebom, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 12, 2022
Optimization of Timing of Maternal Pertussis Immunization From 6 Years of Postimplementation Surveillance Data in EnglandGayatri Amirthalingam, Helen Campbell, Sonia Ribeiro, et al.
The Journal of Infection|March 8, 2012
The effect of underlying clinical conditions on the risk of developing invasive pneumococcal disease in EnglandAlbert Jan van Hoek, Nick Andrews, Pauline A Waight, et al.
Transfusion|February 15, 2017
Hepatitis E risks: pigs or blood-that is the questionRichard S Tedder, Samreen Ijaz, Alan Kitchen, et al.
Clinical and Vaccine Immunology : CVI|August 19, 2007
Immunogenicity of a fourth dose of Haemophilus influenzae type b (Hib) conjugate vaccine and antibody persistence in young children from the United Kingdom who were primed with acellular or whole-cell pertussis component-containing Hib combinations in infancyJo Southern, Jodie McVernon, David Gelb, et al.
The Lancet Regional Health. Europe|November 16, 2022
Effectiveness of the COVID-19 vaccines against hospitalisation with Omicron sub-lineages BA.4 and BA.5 in EnglandFreja Cordelia Møller Kirsebom, Nick Andrews, Julia Stowe, et al.
The Lancet. Healthy Longevity|July 4, 2025
Pneumococcal vaccination for new residents entering older adult care homes in England: national observational surveillance studyFariyo Abdullahi, Tara Patel, Kelly Stoker, et al.
Vaccine|July 26, 2023
Re-evaluation of the risk of venous thromboembolism after COVID-19 vaccination using haematological criteriaRebecca J Shaw, Andrew J Doyle, Emily A Millen, et al.
Pageof 37

Showing results (141-150 of 364) with videos related to

Sort By:
Pageof 37
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 22, 2014
A case-control study to estimate the effectiveness of maternal pertussis vaccination in protecting newborn infants in England and Wales, 2012-2013Gavin Dabrera, Gayatri Amirthalingam, Nick Andrews, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 20, 2020
Characteristics of Invasive Pneumococcal Disease Caused by Emerging Serotypes After the Introduction of the 13-Valent Pneumococcal Conjugate Vaccine in England: A Prospective Observational Cohort Study, 2014-2018Zahin Amin-Chowdhury, Sarah Collins, Carmen Sheppard, et al.
Nature Medicine|January 19, 2022
Effectiveness of COVID-19 booster vaccines against COVID-19-related symptoms, hospitalization and death in EnglandNick Andrews, Julia Stowe, Freja Kirsebom, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 12, 2022
Optimization of Timing of Maternal Pertussis Immunization From 6 Years of Postimplementation Surveillance Data in EnglandGayatri Amirthalingam, Helen Campbell, Sonia Ribeiro, et al.
The Journal of Infection|March 8, 2012
The effect of underlying clinical conditions on the risk of developing invasive pneumococcal disease in EnglandAlbert Jan van Hoek, Nick Andrews, Pauline A Waight, et al.
Transfusion|February 15, 2017
Hepatitis E risks: pigs or blood-that is the questionRichard S Tedder, Samreen Ijaz, Alan Kitchen, et al.
Clinical and Vaccine Immunology : CVI|August 19, 2007
Immunogenicity of a fourth dose of Haemophilus influenzae type b (Hib) conjugate vaccine and antibody persistence in young children from the United Kingdom who were primed with acellular or whole-cell pertussis component-containing Hib combinations in infancyJo Southern, Jodie McVernon, David Gelb, et al.
The Lancet Regional Health. Europe|November 16, 2022
Effectiveness of the COVID-19 vaccines against hospitalisation with Omicron sub-lineages BA.4 and BA.5 in EnglandFreja Cordelia Møller Kirsebom, Nick Andrews, Julia Stowe, et al.
The Lancet. Healthy Longevity|July 4, 2025
Pneumococcal vaccination for new residents entering older adult care homes in England: national observational surveillance studyFariyo Abdullahi, Tara Patel, Kelly Stoker, et al.
Vaccine|July 26, 2023
Re-evaluation of the risk of venous thromboembolism after COVID-19 vaccination using haematological criteriaRebecca J Shaw, Andrew J Doyle, Emily A Millen, et al.
Pageof 37